GADO, FRANCESCA
GADO, FRANCESCA
DIPARTIMENTO DI SCIENZE DEL FARMACO
Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice
2021-01-01 Shapiro, L.; Gado, F.; Manera, C.; Escayg, A.
Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery
2019-01-01 Gado, F.; Meini, S.; Bertini, S.; Digiacomo, M.; Macchia, M.; Manera, C.
Characterization and Otoprotective Effects of Polysaccharides from Arthrospira platensis
2025-01-01 Banti, M.; Garcia-Gil, M.; Guidotti, L.; Di Giuseppe, G.; Rapposelli, S.; Monti, D.; Tampucci, S.; De Leo, M.; Gado, F.; Nieri, P.; Manera, C.
Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold
2025-01-01 Bononi, G.; Gado, F.; Masoni, S.; Scalabrini, D.; Vedova, L. D.; Di Stefano, M.; Piazza, L.; Poles, C.; Lonzi, C.; Landucci, E.; Vagaggini, C.; Poggialini, F.; Brai, A.; Caligiuri, I.; Rizzolio, F.; Mohamed, K. A.; Bertini, S.; De Lorenzi, E.; Dreassi, E.; Macchia, M.; Minutolo, F.; Laprairie, R. B.; Granchi, C.; Tuccinardi, T.
Medicinal Chemistry approach, pharmacology and neuroprotective benefits of {CB}2R modulators in neurodegenerative diseases
2021-01-01 Ferrisi, Rebecca; Ceni, Costanza; Bertini, Simone; Macchia, Marco; Manera, Clementina; Gado, Francesca
Multi-Target Protective Effects of β-Caryophyllene (BCP) at the Intersection of Neuroinflammation and Neurodegeneration
2025-01-01 Ricardi, C.; Mazzierli, A.; Guglielmo, S.; Origlia, N.; Gado, F.; Manera, C.; Chiellini, G.; Polini, B.
Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor
2017-01-01 Bertini, S.; Chicca, A.; Gado, F.; Arena, C.; Nieri, D.; Digiacomo, M.; Saccomanni, G.; Zhao, P.; Abood, M. E.; Macchia, M.; Gertsch, J.; Manera, C.
Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist
2020-01-01 Polini, B.; Cervetto, C.; Carpi, S.; Pelassa, S.; Gado, F.; Ferrisi, R.; Bertini, S.; Nieri, P.; Marcoli, M.; Manera, C.
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
2022-01-01 Gado, F.; Ferrisi, R.; Di Somma, S.; Napolitano, F.; Mohamed, K. A.; Stevenson, L. A.; Rapposelli, S.; Saccomanni, G.; Portella, G.; Pertwee, R. G.; Laprairie, R. B.; Malfitano, A. M.; Manera, C.
Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity
2020-01-01 Brizzi, A.; Aiello, F.; Boccella, S.; Cascio, M. G.; De Petrocellis, L.; Frosini, M.; Gado, F.; Ligresti, A.; Luongo, L.; Marini, P.; Mugnaini, C.; Pessina, F.; Corelli, F.; Maione, S.; Manera, C.; Pertwee, R. G.; Di Marzo, V.
Targeting cannabinoid 2 receptors in chronic lymphocytic leukaemia: Utility of positive allosteric modulators
2019-01-01 Al Bakour, Z; Gado, F; Vickers, M; Pertwee, R; Hislop, J; Manera, C; Murray, F
The Carnosine–HNE Michael Adduct as a Redox-Active Species Associated with Nrf2-Dependent Antioxidant and Anti-Inflammatory Responses
2026-01-01 Altomare, Alessandra; Baron, Giovanna; Gado, Francesca; Vedova, Larissa Della; Ferrario, Giulio; Davani, Lara; Gilardoni, Ettore; Ferrisi, Rebecca; Mocchetti, Clara; Singh, Lavpreet; Courten, Barbora De; Carini, Marina; Siracusa, Rosalba; D'Amico, Ramona; Di Paola, Rosanna; Dallanoce, Clelia; Impellizzeri, Daniela; Aldini, Giancarlo
Watermelon: setup and validation of an in silico fragment-based approach
2024-01-01 Di Stefano, M.; Galati, S.; Piazza, L.; Gado, F.; Granchi, C.; Macchia, M.; Giordano, A.; Tuccinardi, T.; Poli, G.
White Grape Skin Extraction, Analytical Profile, and Biological Activity: From the Laboratory to the Industrial Scale Within a Circular Economy Framework
2025-01-01 Della Vedova, L.; Baron, G.; Morazzoni, P.; Santinello, S.; El Haddad, S. M.; Valdes-Gonzalez, J. A.; Piazza, S.; Dell'Agli, M.; Aldini, G.; Gado, F.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Allosteric modulation of the cannabinoid 2 receptor confers seizure resistance in mice | 1-gen-2021 | Shapiro, L.; Gado, F.; Manera, C.; Escayg, A. | |
| Allosteric modulators targeting cannabinoid cb1 and cb2 receptors: Implications for drug discovery | 1-gen-2019 | Gado, F.; Meini, S.; Bertini, S.; Digiacomo, M.; Macchia, M.; Manera, C. | |
| Characterization and Otoprotective Effects of Polysaccharides from Arthrospira platensis | 1-gen-2025 | Banti, M.; Garcia-Gil, M.; Guidotti, L.; Di Giuseppe, G.; Rapposelli, S.; Monti, D.; Tampucci, S.; De Leo, M.; Gado, F.; Nieri, P.; Manera, C. | |
| Discovery of reversible monoacylglycerol lipase (MAGL) inhibitors based on ortho-hydroxyanilide scaffold | 1-gen-2025 | Bononi, G.; Gado, F.; Masoni, S.; Scalabrini, D.; Vedova, L. D.; Di Stefano, M.; Piazza, L.; Poles, C.; Lonzi, C.; Landucci, E.; Vagaggini, C.; Poggialini, F.; Brai, A.; Caligiuri, I.; Rizzolio, F.; Mohamed, K. A.; Bertini, S.; De Lorenzi, E.; Dreassi, E.; Macchia, M.; Minutolo, F.; Laprairie, R. B.; Granchi, C.; Tuccinardi, T. | |
| Medicinal Chemistry approach, pharmacology and neuroprotective benefits of {CB}2R modulators in neurodegenerative diseases | 1-gen-2021 | Ferrisi, Rebecca; Ceni, Costanza; Bertini, Simone; Macchia, Marco; Manera, Clementina; Gado, Francesca | |
| Multi-Target Protective Effects of β-Caryophyllene (BCP) at the Intersection of Neuroinflammation and Neurodegeneration | 1-gen-2025 | Ricardi, C.; Mazzierli, A.; Guglielmo, S.; Origlia, N.; Gado, F.; Manera, C.; Chiellini, G.; Polini, B. | |
| Novel analogs of PSNCBAM-1 as allosteric modulators of cannabinoid CB1 receptor | 1-gen-2017 | Bertini, S.; Chicca, A.; Gado, F.; Arena, C.; Nieri, D.; Digiacomo, M.; Saccomanni, G.; Zhao, P.; Abood, M. E.; Macchia, M.; Gertsch, J.; Manera, C. | |
| Positive allosteric modulation of CB1 and CB2 cannabinoid receptors enhances the neuroprotective activity of a dual CB1R/CB2R orthosteric agonist | 1-gen-2020 | Polini, B.; Cervetto, C.; Carpi, S.; Pelassa, S.; Gado, F.; Ferrisi, R.; Bertini, S.; Nieri, P.; Marcoli, M.; Manera, C. | |
| Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells | 1-gen-2022 | Gado, F.; Ferrisi, R.; Di Somma, S.; Napolitano, F.; Mohamed, K. A.; Stevenson, L. A.; Rapposelli, S.; Saccomanni, G.; Portella, G.; Pertwee, R. G.; Laprairie, R. B.; Malfitano, A. M.; Manera, C. | |
| Synthetic bioactive olivetol-related amides: The influence of the phenolic group in cannabinoid receptor activity | 1-gen-2020 | Brizzi, A.; Aiello, F.; Boccella, S.; Cascio, M. G.; De Petrocellis, L.; Frosini, M.; Gado, F.; Ligresti, A.; Luongo, L.; Marini, P.; Mugnaini, C.; Pessina, F.; Corelli, F.; Maione, S.; Manera, C.; Pertwee, R. G.; Di Marzo, V. | |
| Targeting cannabinoid 2 receptors in chronic lymphocytic leukaemia: Utility of positive allosteric modulators | 1-gen-2019 | Al Bakour, Z; Gado, F; Vickers, M; Pertwee, R; Hislop, J; Manera, C; Murray, F | |
| The Carnosine–HNE Michael Adduct as a Redox-Active Species Associated with Nrf2-Dependent Antioxidant and Anti-Inflammatory Responses | 1-gen-2026 | Altomare, Alessandra; Baron, Giovanna; Gado, Francesca; Vedova, Larissa Della; Ferrario, Giulio; Davani, Lara; Gilardoni, Ettore; Ferrisi, Rebecca; Mocchetti, Clara; Singh, Lavpreet; Courten, Barbora De; Carini, Marina; Siracusa, Rosalba; D'Amico, Ramona; Di Paola, Rosanna; Dallanoce, Clelia; Impellizzeri, Daniela; Aldini, Giancarlo | |
| Watermelon: setup and validation of an in silico fragment-based approach | 1-gen-2024 | Di Stefano, M.; Galati, S.; Piazza, L.; Gado, F.; Granchi, C.; Macchia, M.; Giordano, A.; Tuccinardi, T.; Poli, G. | |
| White Grape Skin Extraction, Analytical Profile, and Biological Activity: From the Laboratory to the Industrial Scale Within a Circular Economy Framework | 1-gen-2025 | Della Vedova, L.; Baron, G.; Morazzoni, P.; Santinello, S.; El Haddad, S. M.; Valdes-Gonzalez, J. A.; Piazza, S.; Dell'Agli, M.; Aldini, G.; Gado, F. |